These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21916086)

  • 1. [Sugammadex: a new approach to the use of neuromuscular blockers].
    Alvarez-Gómez JA; Veiga-Ruiz G
    Rev Esp Anestesiol Reanim; 2011 Jun; 58 Suppl 2():20-3. PubMed ID: 21916086
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 3. Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions.
    Akha AS; Rosa J; Jahr JS; Li A; Kiai K
    Anesthesiol Clin; 2010 Dec; 28(4):691-708. PubMed ID: 21074746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Have we learned how to relax our patients, by thinking outside the box?
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
    Carron M; Parotto E; Ori C
    Minerva Anestesiol; 2012 Jan; 78(1):112-3. PubMed ID: 22237790
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrins and the emergence of sugammadex.
    Booij LH
    Anaesthesia; 2009 Mar; 64 Suppl 1():31-7. PubMed ID: 19222429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
    Ren WH; Jahr JS
    Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex: an opportunity to change the practice of anesthesiology?
    Miller RD
    Anesth Analg; 2007 Mar; 104(3):477-8. PubMed ID: 17312188
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful use of rocuronium and sugammadex in a patient with myasthenia.
    Petrun AM; Mekis D; Kamenik M
    Eur J Anaesthesiol; 2010 Oct; 27(10):917-8. PubMed ID: 20375901
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of sugammadex in a patient with myotonic dystrophy.
    Matsuki Y; Hirose M; Tabata M; Nobukawa Y; Shigemi K
    Eur J Anaesthesiol; 2011 Feb; 28(2):145-6. PubMed ID: 20962659
    [No Abstract]   [Full Text] [Related]  

  • 18. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex: a novel approach to reversal of neuromuscular blockade.
    Aniskevich S; Leone BJ; Brull SJ
    Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecule of the month. Sugammadex sodium.
    Drug News Perspect; 2007 Nov; 20(9):591-2. PubMed ID: 18176664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.